Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2010
05/20/2010WO2010002983A3 Composition and methods for eliciting an immune response
05/20/2010WO2010002867A3 Multivalent antihelminthic vaccine
05/20/2010WO2009106073A3 Mhc multimers in borrelia diagnostics and disease
05/20/2010US20100125101 Immunostimulatory nucleic acid molecules
05/20/2010US20100124567 Stabilizing alkylglycoside compositions and methods thereof
05/20/2010US20100124559 Early Treatment and Prevention of Increased Muscle Tonicity
05/20/2010US20100124558 Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety
05/20/2010US20100124557 Vaccine formulations and uses thereof
05/20/2010US20100124556 Novel shigella protein antigens and methods
05/20/2010US20100124555 Compositions and Methods for Treating Pancreatic Tumors
05/20/2010US20100124554 Redox-active compounds and related compounds, compositions, methods and systems
05/20/2010US20100124553 Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy
05/20/2010US20100124552 Peptide biomarkers of cardiovascular disease
05/20/2010US20100124551 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
05/20/2010US20100124550 Amide inhibitors of renin
05/20/2010US20100124544 Crystalline forms of dihydropyrazolopyrimidinone
05/20/2010DE102008057451A1 Verfahren zur oralen Vakzinierung mittels rekombinanter Hefen Method for oral vaccination using recombinant yeast
05/20/2010DE102008037564A1 Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden Composition for the production of anti-amyloid beta-peptide antibodies with peptides D-
05/20/2010CA2747918A1 Vaccine formulations and uses thereof
05/20/2010CA2744120A1 A vaccinia virus protein a46 peptide and use thereof
05/20/2010CA2743660A1 Vaccine strains of brachyspira hyodysenteriae
05/20/2010CA2743649A1 Agents and treatment for snoring and respiratory effort related arousals in sleep
05/20/2010CA2743487A1 Cd37 immunotherapeutic combination therapies and uses thereof
05/20/2010CA2743469A1 Antibody formulation
05/20/2010CA2743464A1 Therapeutic and diagnostic methods relating to cancer stem cells
05/20/2010CA2743306A1 Human m2e peptide immunogens
05/20/2010CA2743305A1 Anti-cxcr1 compositions and methods
05/20/2010CA2743262A1 Eimeria vaccine for turkeys
05/20/2010CA2742990A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
05/20/2010CA2742988A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
05/20/2010CA2742871A1 Methods and compositions for regulating iron homeostasis by modulation bmp-6
05/20/2010CA2742786A1 Humanized anti-il-6 antibodies
05/20/2010CA2739352A1 Methods for purification of single domain antigen binding molecules
05/20/2010CA2707026A1 Anti-human il-21 monoclonal antibodies
05/19/2010EP2186896A1 Cancer antigen peptides derived from WT1
05/19/2010EP2186894A1 Monoclonal antibody having neutralizing activity against mmp13
05/19/2010EP2186893A1 Production and use of epitope-tagged hepatitis c virus particle
05/19/2010EP2186892A1 Anti-cd20 monoclonal antibodies
05/19/2010EP2186889A1 Cdca1 peptide and pharmaceutical agent comprising the same
05/19/2010EP2186829A1 Antibodies against GPIbalpha
05/19/2010EP2186820A1 Protein-protein interactions in human immunodeficiency virus
05/19/2010EP2186527A1 Compositions comprising polypeptides
05/19/2010EP2186526A1 Cell-penetrating peptides and use thereof bonded to biomolecules with therapeutic action
05/19/2010EP2186015A2 De-duplication in virtualized server and virtualized storage environments
05/19/2010EP2185933A2 Matriptase protein and uses thereof
05/19/2010EP2185732A1 Cancer associated gene ly6k
05/19/2010EP2185686A1 Dendritic cells
05/19/2010EP2185592A1 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
05/19/2010EP2185591A1 Production method
05/19/2010EP2185589A2 Immunoglobulin constant region fc receptor binding agents
05/19/2010EP2185579A1 Complexes of grp94 with human immunoglobulin g
05/19/2010EP2185578A2 Genes and proteins of brachyspira hyodysenteriae and uses thereof
05/19/2010EP2185201A1 Compositions and methods for crystallizing antibodies
05/19/2010EP2185199A2 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
05/19/2010EP2185198A1 Lox and l0xl2 inhibitors and uses thereof
05/19/2010EP2185197A1 Novel cellular factor- containing solution compositions
05/19/2010EP2185195A2 Immunogen platform
05/19/2010EP2185194A2 Idiotypic vaccine
05/19/2010EP2185192A2 Lentiviral gene transfer vectors and their medicinal applications
05/19/2010EP2185191A2 Low-additive influenza vaccines
05/19/2010EP2185190A1 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
05/19/2010EP2185189A1 Capsule composition for use as immunogen against campylobacter jejuni
05/19/2010EP2185188A1 Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions
05/19/2010EP2185164A1 Composition and therapeutic anti-tumour vaccine
05/19/2010EP2185160A2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
05/19/2010EP2185145A1 Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
05/19/2010EP1759013B1 Identification of surface-associated antigens for tumor diagnosis and therapy
05/19/2010EP1689783B1 Mutated anti-cd22 antibodies and immunoconjugates
05/19/2010EP1448584B1 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
05/19/2010EP1368060B1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
05/19/2010EP1214097B9 Nucleic acids encoding polyepitope polypeptides
05/19/2010EP1115382B1 Immunogenic liposome compositions
05/19/2010EP0907735B9 Modulators of tissue regeneration
05/19/2010CN1986562B Polypeptide segment capable of enhancing animal's antibody response and its application
05/19/2010CN101711284A Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
05/19/2010CN101711280A TEM8 peptides and vaccines comprising the same
05/19/2010CN101711256A Antibodies against IL-25
05/19/2010CN101711165A Artificial invaplex
05/19/2010CN101711164A Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
05/19/2010CN101709089A Monoclonal antibody for resisting Cyr61 protein and application thereof
05/19/2010CN101709088A Monoclonal antibody for resisting Cyr61 protein and application thereof
05/19/2010CN101709080A Synthetic peptide vaccine for resisting porcine circovirus and preparation method thereof
05/19/2010CN101708333A Multivalent vaccine composition
05/19/2010CN101708332A Rabbit triple inactivated vaccine, preparation method and application thereof
05/19/2010CN101708331A Novel human rabies vaccine and method for preparing same
05/19/2010CN101708330A Antibody-containing chicken egg protein injection for controlling swine fever (diseases)
05/19/2010CN101708165A Microspheres for active embolization
05/19/2010CN101157907B Recombinant salmonella choleraesuis strain for expression of pig origin bordetella bronchisepatica fhaB and prn gene segment, bacterin and uses thereof
05/19/2010CN101085347B Hepatitis A, hepatitis B and hepatitis E combination vaccine
05/19/2010CN101044884B Method for prepairng feed additives containing yolk anti body
05/18/2010US7718779 Prophylactic and therapeutic monoclonal antibodies
05/18/2010US7718777 MHC-peptide complex binding ligands
05/18/2010US7718776 Comprises monoclonal antibody which specifically binds osteoprotegerin ligand (OPGL) for diagnosis, prevention and treatment of bone disorders
05/18/2010US7718774 TES7 and antibodies that bind thereto
05/18/2010US7718772 Canine thymic stromal lymphopoietin protein and uses thereof
05/18/2010US7718764 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
05/18/2010US7718762 stimulate T cytotoxic lymphocytes in a mammal
05/18/2010US7718627 Plasmid comprising nucleotide sequences coding immunoglobulin complementary determining regions specific to tumor antigen (5T4); for use in delivering product and/or nucleotide sequences of interest to tumor; drug delivery
05/18/2010US7718623 Immunostimulatory oligonucleotide that induces interferon alpha
05/18/2010US7718622 freezing dried biochemical conjugated immunomodulator comprising immunostimulatory polynucleotide sequence and plant Ragweed allergen; genetic vaccines
1 ... 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 ... 1823